Cargando…
Contribution of QuantiFERON-TB Gold-in-Tube to the Diagnosis of Mycobacterium tuberculosis Infection in Young Children in a Low TB Prevalence Country
Introduction: Interferon Gamma Release Assay (IGRA) has proven to be a useful test to evaluate the immune response to Mycobacterium tuberculosis antigens in children over the age of 5 years as an alternative to tuberculin skin testing (TST). Much less is known about its performance in younger childr...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657736/ https://www.ncbi.nlm.nih.gov/pubmed/31380325 http://dx.doi.org/10.3389/fped.2019.00291 |
_version_ | 1783438843373944832 |
---|---|
author | Debulpaep, Sara Corbière, Véronique Levy, Jack Schelstraete, Petra Vanden Driessche, Koen Mascart, Françoise Mouchet, Françoise |
author_facet | Debulpaep, Sara Corbière, Véronique Levy, Jack Schelstraete, Petra Vanden Driessche, Koen Mascart, Françoise Mouchet, Françoise |
author_sort | Debulpaep, Sara |
collection | PubMed |
description | Introduction: Interferon Gamma Release Assay (IGRA) has proven to be a useful test to evaluate the immune response to Mycobacterium tuberculosis antigens in children over the age of 5 years as an alternative to tuberculin skin testing (TST). Much less is known about its performance in younger children, who are at higher risk for developing tuberculosis (TB) disease after exposure. We aimed to evaluate the accuracy of using IGRA in TB screening in this population. Methods: Children below the age of 5 years at high risk for TB infection were prospectively enrolled, to compare the performance of TST and the QuantiFERON-TB Gold-In-Tube test (QFT). Children were treated in accordance with the diagnosis made at baseline and followed-up for 12 months. Results: We included a total of 60 children of which 97 blood samples were available for analysis. There was 90.72% agreement between TST and QFT (Kappa test 0.59, moderate agreement). With TST as a reference, the QFT positive predictive value was 0.72 and the negative predictive value 0.93. Discordant results were observed with 6% TST+/QFT– paired tests. When we restricted the comparison of TST and QFT to non-BCG-vaccinated children, the degree of agreement was more substantial (95%, Kappa test 0.75) and the negative predictive value was 0.99. We observed 3% discordant TST–/QFT+ results. All children with active TB disease had concordant positive QFT results, with QFT values above 4.00 IU/ml. Conclusion: In a low TB prevalence country, serial testing of QFT was found to produce a moderate agreement with TST results. False positive QFT results would have been eliminated by using a higher cutoff without misdiagnosing the children with TB disease. Some of the false negative QFT results could be explained by false positive TST results on consecutive testing. For now the most prudent approach would be to consider discordant QFT–/TST+ results as false negative QFT results, taking into account the young age of our population and the potential risk for evolution to active TB disease. |
format | Online Article Text |
id | pubmed-6657736 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-66577362019-08-02 Contribution of QuantiFERON-TB Gold-in-Tube to the Diagnosis of Mycobacterium tuberculosis Infection in Young Children in a Low TB Prevalence Country Debulpaep, Sara Corbière, Véronique Levy, Jack Schelstraete, Petra Vanden Driessche, Koen Mascart, Françoise Mouchet, Françoise Front Pediatr Pediatrics Introduction: Interferon Gamma Release Assay (IGRA) has proven to be a useful test to evaluate the immune response to Mycobacterium tuberculosis antigens in children over the age of 5 years as an alternative to tuberculin skin testing (TST). Much less is known about its performance in younger children, who are at higher risk for developing tuberculosis (TB) disease after exposure. We aimed to evaluate the accuracy of using IGRA in TB screening in this population. Methods: Children below the age of 5 years at high risk for TB infection were prospectively enrolled, to compare the performance of TST and the QuantiFERON-TB Gold-In-Tube test (QFT). Children were treated in accordance with the diagnosis made at baseline and followed-up for 12 months. Results: We included a total of 60 children of which 97 blood samples were available for analysis. There was 90.72% agreement between TST and QFT (Kappa test 0.59, moderate agreement). With TST as a reference, the QFT positive predictive value was 0.72 and the negative predictive value 0.93. Discordant results were observed with 6% TST+/QFT– paired tests. When we restricted the comparison of TST and QFT to non-BCG-vaccinated children, the degree of agreement was more substantial (95%, Kappa test 0.75) and the negative predictive value was 0.99. We observed 3% discordant TST–/QFT+ results. All children with active TB disease had concordant positive QFT results, with QFT values above 4.00 IU/ml. Conclusion: In a low TB prevalence country, serial testing of QFT was found to produce a moderate agreement with TST results. False positive QFT results would have been eliminated by using a higher cutoff without misdiagnosing the children with TB disease. Some of the false negative QFT results could be explained by false positive TST results on consecutive testing. For now the most prudent approach would be to consider discordant QFT–/TST+ results as false negative QFT results, taking into account the young age of our population and the potential risk for evolution to active TB disease. Frontiers Media S.A. 2019-07-18 /pmc/articles/PMC6657736/ /pubmed/31380325 http://dx.doi.org/10.3389/fped.2019.00291 Text en Copyright © 2019 Debulpaep, Corbière, Levy, Schelstraete, Vanden Driessche, Mascart and Mouchet. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pediatrics Debulpaep, Sara Corbière, Véronique Levy, Jack Schelstraete, Petra Vanden Driessche, Koen Mascart, Françoise Mouchet, Françoise Contribution of QuantiFERON-TB Gold-in-Tube to the Diagnosis of Mycobacterium tuberculosis Infection in Young Children in a Low TB Prevalence Country |
title | Contribution of QuantiFERON-TB Gold-in-Tube to the Diagnosis of Mycobacterium tuberculosis Infection in Young Children in a Low TB Prevalence Country |
title_full | Contribution of QuantiFERON-TB Gold-in-Tube to the Diagnosis of Mycobacterium tuberculosis Infection in Young Children in a Low TB Prevalence Country |
title_fullStr | Contribution of QuantiFERON-TB Gold-in-Tube to the Diagnosis of Mycobacterium tuberculosis Infection in Young Children in a Low TB Prevalence Country |
title_full_unstemmed | Contribution of QuantiFERON-TB Gold-in-Tube to the Diagnosis of Mycobacterium tuberculosis Infection in Young Children in a Low TB Prevalence Country |
title_short | Contribution of QuantiFERON-TB Gold-in-Tube to the Diagnosis of Mycobacterium tuberculosis Infection in Young Children in a Low TB Prevalence Country |
title_sort | contribution of quantiferon-tb gold-in-tube to the diagnosis of mycobacterium tuberculosis infection in young children in a low tb prevalence country |
topic | Pediatrics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657736/ https://www.ncbi.nlm.nih.gov/pubmed/31380325 http://dx.doi.org/10.3389/fped.2019.00291 |
work_keys_str_mv | AT debulpaepsara contributionofquantiferontbgoldintubetothediagnosisofmycobacteriumtuberculosisinfectioninyoungchildreninalowtbprevalencecountry AT corbiereveronique contributionofquantiferontbgoldintubetothediagnosisofmycobacteriumtuberculosisinfectioninyoungchildreninalowtbprevalencecountry AT levyjack contributionofquantiferontbgoldintubetothediagnosisofmycobacteriumtuberculosisinfectioninyoungchildreninalowtbprevalencecountry AT schelstraetepetra contributionofquantiferontbgoldintubetothediagnosisofmycobacteriumtuberculosisinfectioninyoungchildreninalowtbprevalencecountry AT vandendriesschekoen contributionofquantiferontbgoldintubetothediagnosisofmycobacteriumtuberculosisinfectioninyoungchildreninalowtbprevalencecountry AT mascartfrancoise contributionofquantiferontbgoldintubetothediagnosisofmycobacteriumtuberculosisinfectioninyoungchildreninalowtbprevalencecountry AT mouchetfrancoise contributionofquantiferontbgoldintubetothediagnosisofmycobacteriumtuberculosisinfectioninyoungchildreninalowtbprevalencecountry |